Companies House SC844452 2026-04-30 2026-04-30 2025-04-08 false iso4217:GBP xbrli:pure SC844452 2026-04-30 SC844452 2025-04-08 2026-04-30 SC844452 curr:PoundSterling 2025-04-08 2026-04-30 SC844452 uk-bus:PrivateLimitedCompanyLtd 2025-04-08 2026-04-30 SC844452 uk-bus:FRS102 2025-04-08 2026-04-30 SC844452 uk-bus:AuditExempt-NoAccountantsReport 2025-04-08 2026-04-30 SC844452 uk-bus:FullAccounts 2025-04-08 2026-04-30 SC844452 uk-bus:RegisteredOffice 2025-04-08 2026-04-30 SC844452 uk-bus:Director1 2025-04-08 2026-04-30 SC844452 uk-bus:Director2 2025-04-08 2026-04-30 SC844452 uk-bus:Director3 2025-04-08 2026-04-30 SC844452 uk-bus:Director4 2025-04-08 2026-04-30 SC844452 uk-bus:Director5 2025-04-08 2026-04-30 SC844452 uk-bus:Director6 2025-04-08 2026-04-30 SC844452 uk-bus:Director7 2025-04-08 2026-04-30 SC844452 uk-bus:Director8 2025-04-08 2026-04-30 SC844452 uk-bus:Director9 2025-04-08 2026-04-30 SC844452 uk-bus:Director10 2025-04-08 2026-04-30 SC844452 uk-bus:Director11 2025-04-08 2026-04-30 SC844452 uk-bus:Director12 2025-04-08 2026-04-30 SC844452 uk-bus:Director13 2025-04-08 2026-04-30 SC844452 uk-bus:Director14 2025-04-08 2026-04-30 SC844452 uk-bus:Director15 2025-04-08 2026-04-30 SC844452 uk-bus:Director16 2025-04-08 2026-04-30 SC844452 uk-bus:Director17 2025-04-08 2026-04-30 SC844452 uk-bus:Director18 2025-04-08 2026-04-30 SC844452 uk-bus:Director19 2025-04-08 2026-04-30 SC844452 uk-bus:Director20 2025-04-08 2026-04-30 SC844452 uk-bus:Director21 2025-04-08 2026-04-30 SC844452 uk-bus:CompanySecretary1 2025-04-08 2026-04-30 SC844452 core:AfterOneYear 2026-04-30 SC844452 core:WithinOneYear 2026-04-30 SC844452 core:WithinOneYear 2025-04-08 2026-04-30 SC844452 core:AfterOneYear 2026-04-30 SC844452 core:AfterOneYear 2025-04-08 2026-04-30 SC844452 core:ShareCapital 2026-04-30 SC844452 core:SharePremium 2026-04-30 SC844452 core:OtherReservesSubtotal 2026-04-30 SC844452 core:RevaluationReserve 2026-04-30 SC844452 core:RetainedEarningsAccumulatedLosses 2026-04-30 SC844452 1 2025-04-08 2026-04-30 SC844452 2 2025-04-08 2026-04-30 SC844452 3 2025-04-08 2026-04-30 SC844452 core:LandBuildings 2025-04-08 2026-04-30 SC844452 core:LandBuildings 2026-04-30 SC844452 core:PlantMachinery 2025-04-08 2026-04-30 SC844452 core:PlantMachinery 2026-04-30 SC844452 core:FurnitureFittingsToolsEquipment 2025-04-08 2026-04-30 SC844452 core:FurnitureFittingsToolsEquipment 2026-04-30 SC844452 core:OfficeEquipment 2025-04-08 2026-04-30 SC844452 core:OfficeEquipment 2026-04-30 SC844452 core:Vehicles 2025-04-08 2026-04-30 SC844452 core:Vehicles 2026-04-30 SC844452 core:NetGoodwill 2025-04-08 2026-04-30 SC844452 core:NetGoodwill 2026-04-30 SC844452 core:IntangibleAssetsOtherThanGoodwill 2025-04-08 2026-04-30 SC844452 core:IntangibleAssetsOtherThanGoodwill 2026-04-30

# ZEMBIOTECH LTD

## Company Registration Number:
SC844452 (Scotland)

## Unaudited statutory accounts for the year ended 30 April 2026

## Period of accounts

## Start date: 8 April 2025

## End date: 30 April 2026

# ZEMBIOTECH LTD

## Contents of the Financial Statements

for the Period Ended 30 April 2026

Profit and loss |
Balance sheet |
Additional notes |
Balance sheet notes |

# ZEMBIOTECH LTD

## Profit And Loss Account

for the Period Ended 30 April 2026

| 13 months to 30 April 2026
--- | ---
| £
Turnover: | 473 |
Cost of sales: | ( 451 ) |
Gross profit(or loss): | 22
Administrative expenses: | ( 11 ) |
Other operating income: | 0 |
Operating profit(or loss): | 11
Interest receivable and similar income: | 0 |
Interest payable and similar charges: | 0 |
Profit(or loss) before tax: | 11
Tax: | 0 |
Profit(or loss) for the financial year: | 11

# ZEMBIOTECH LTD

## Balance sheet

As at 30 April 2026

| Notes | 13 months to 30 April 2026
--- | --- | ---
|  | £
Called up share capital not paid: |  | 0 |
Fixed assets
Intangible assets: |  | 0 |
Tangible assets: |  | 0 |
Investments: |  | 0 |
Total fixed assets: |  | 0
Current assets
Stocks: |  | 0 |
Debtors: |  | 0 |
Cash at bank and in hand: |  | 402 |
Investments: |  | 0 |
Total current assets: |  | 402
Prepayments and accrued income: |  | 0 |
Creditors: amounts falling due within one year: | 3 | ( 390 ) |
Net current assets (liabilities): |  | 12
Total assets less current liabilities: |  | 12
Creditors: amounts falling due after more than one year: |  | 0 |
Provision for liabilities: |  | 0 |
Accruals and deferred income: |  | 0 |
Total net assets (liabilities): |  | 12
Capital and reserves
Called up share capital: |  | 1 |
Share premium account: |  | 0 |
Other reserves: |  | 0 |
Profit and loss account: |  | 11 |
Total Shareholders' funds: |  | 12

The notes form part of these financial statements

# ZEMBIOTECH LTD

## Balance sheet statements

For the year ending 30 April 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 31 May 2026
and signed on behalf of the board by:

Name: Muhammad Nadeem Kardar
Status: Director

The notes form part of these financial statements

# ZEMBIOTECH LTD

## Notes to the Financial Statements

for the Period Ended 30 April 2026

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

  Turnover policy

  All turnover arose from the company's principal activity within the United Kingdom.

  Other accounting policies

  a. Basis of Preparation The financial statements have been compiled using the historical cost convention. The company’s functional and presentational currency is Pounds Sterling (£), and all figures are presented in this currency. b. Going Concern These accounts are prepared on a going concern basis. After reviewing the company’s financial position, the director is confident that the business possesses sufficient resources to maintain operations for the foreseeable future. c. Revenue Recognition Revenue represents the fair value of money received or expected for goods sold during normal business operations. The company recognizes revenue when control of the goods transfers to the buyer, the final amount can be reliably calculated, and it is probable that the financial benefits will be received. d. Financial Instruments The company complies with Sections 11 and 12 of FRS 102 regarding financial instruments. Basic financial assets and liabilities are recorded at their transaction price at start and later tracked at amortised cost, where applicable. The company's financial instruments consist exclusively of cash at bank and the director's loan account. e. Cash and Cash Equivalents Cash and cash equivalents include all money held as cash in hand and funds stored in bank accounts. f. Taxation Current tax is calculated based on the taxable profits of the financial year. The company uses tax rates that are legally enacted or substantively enacted by the official reporting date.

# ZEMBIOTECH LTD

## Notes to the Financial Statements

for the Period Ended 30 April 2026

- ## 2. Employees

  | 13 months to 30 April 2026
  --- | ---
  Average number of employees during the period | 0 |

# ZEMBIOTECH LTD

## Notes to the Financial Statements

for the Period Ended 30 April 2026

## 3. Creditors: amounts falling due within one year note

| 13 months to 30 April 2026
--- | ---
| £
Bank loans and overdrafts | 0 |
Amounts due under finance leases and hire purchase contracts | 0 |
Trade creditors | 0 |
Taxation and social security | 0 |
Accruals and deferred income | 0 |
Other creditors | 390 |
Total | 390